Adrenal cancer researchers spanning 39 institutions identified new genetic drivers of the disease. The results make way for future treatment advances.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
A biomarker associated with basal cell carcinoma may help signal which tumors will be more aggressive, a new U-M study finds.
A new U-M study examines how media coverage of celebrity health has influenced breast cancer treatment decisions.
Categorizing non-life-threatening thyroid tumors separately from more aggressive thyroid cancers could change patients’ lives for the better, researchers say.
New research explores how a patient’s own immune system might help determine effective treatment options for head and neck cancer.
For breast cancer patients, worry about recurrence is understandable. But up to a third of patients at low risk of distant recurrence overestimate their risk — and it’s affecting their quality of life.